CounterPath (NASDAQ:CPAH) Stock Price Passes Below 200 Day Moving Average of $1.60

CounterPath, Corp. (NASDAQ:CPAH) (TSE:CCV) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.60 and traded as low as $1.21. CounterPath shares last traded at $1.21, with a volume of 148 shares traded.

Separately, ValuEngine upgraded shares of CounterPath from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st.

The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.84 and a current ratio of 0.84. The stock’s 50-day simple moving average is $1.45 and its two-hundred day simple moving average is $1.60.

A hedge fund recently bought a new stake in CounterPath stock. Wedbush Securities Inc. acquired a new stake in shares of CounterPath, Corp. (NASDAQ:CPAH) (TSE:CCV) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 26,000 shares of the software maker’s stock, valued at approximately $43,000. Wedbush Securities Inc. owned about 0.44% of CounterPath as of its most recent SEC filing. 1.47% of the stock is owned by institutional investors and hedge funds.

About CounterPath (NASDAQ:CPAH)

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. Its products include Bria softphone suite, which enables consumers and business users to make voice over Internet protocol (VoIP) audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and X-Lite, a standards-based VoIP softphone application that runs on desktop computers.

Recommended Story: Quick Ratio

Receive News & Ratings for CounterPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath and related companies with's FREE daily email newsletter.